Jirapinyo, Pichamol https://orcid.org/0000-0001-5273-6851
Jaroenlapnopparat, Aunchalee
Zucker, Stephen D.
Thompson, Christopher C.
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK034854)
Article History
Received: 22 December 2023
Revised: 14 March 2024
Accepted: 14 March 2024
First Online: 21 March 2024
Declarations
:
: For this type of study formal consent is not required.
: Informed consent does not apply.
: Pichamol Jirapinyo, MD, has received research support from Apollo Endosurgery, Boston Scientific, Fractyl, GI Dynamics and USGI Medical; has served as a consultant to Apollo Endosurgery, ERBE, GI Dynamics and Spatz Medical; and has received royalty from Endosim.Christopher C. Thompson, MD, has served as a consultant for Apollo Endosurgery, Boston Scientific, Endoquest Robotics, Enterasense, EnVision Endoscopy, Fractyl, USGI Medical, Medtronic/Covidien, Olympus/Spiration, GI Dynamics, and Xenter; has served as an advisory boards member for USGI Medical and Fractyl; has received research grant and support from USGI Medical, Apollo Endosurgery, Boston Scientific, Endoquest Robotics, ERBE, FujiFilm, Lumendi Olympus/Spiration, Aspire Bariatrics and GI Dynamics; has served as a general partners for Blueframe Healthcare; has served as a founder for Enterasense, EnVision Endoscopy and GI Windows; and holds stock and royalties for GI Windows.Aunchalee Jaroenlapnopparat, MD and Stephen D. Zucker, MD have no conflict of interest.